We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome (34-DAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01373333
Recruitment Status : No longer available
First Posted : June 14, 2011
Last Update Posted : July 20, 2016
Sponsor:
Information provided by (Responsible Party):
The Cleveland Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : No longer available
  Estimated Primary Completion Date : September 2012
  Study Completion Date : No date given